We read with interest the article by Pollack et al. The article presents an analysis of the epidemiology, treatment and monitoring of treatment outcomes and side effects of 392 patients presenting to an ED with hyperkalaemia.
The authors concluded that most ED patients with hyperkalaemia have identifiable clinical and medication-related risk factors. Variations in care were widespread and monitoring for iatrogenic adverse events was suboptimal.
We congratulate the authors on their efforts in conducting a comprehensive assessment of hyperkalaemia in emergency care and highlighting a very clinically relevant and prevalent topic.